X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CYTK

Closed

Cytokinetics Inc

33.64
+0.60 (+1.82%)
Last Update: 01 Jul 2025 23:02:00
Yesterday: 33.04
Day's Range: 32.66 - 34.38
Send
When Written:
 
35.19
Cytokinetics Inc. is a biopharmaceutical company that develops muscle biology-based therapies for diseases and medical conditions. The company's lead drug candidate is omecamtiv mecarbil, a cardiac myosin activator that is being developed in collaboration with Amgen for the treatment of heart failure. Cytokinetics also has several other drug candidates in various stages of development for the treatment of skeletal muscle disorders, including spinal muscular atrophy and amyotrophic lateral sclerosis. The company was founded in 1997 and is headquartered in South San Francisco, California.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X